Merida Biosciences
50 employees
Biotech/Pharma
Series A · $121.0M
Open positions (6)
Company details
Team Size50
IndustryBiotech/Pharma
Funding
Total raised
$121.0M
Last stage
Series A
Investors
Third Rock Ventures
Total raised
$121.0M
Last stage
Series A
Investors
Dario Gutierrez
Ph.D. in molecular physiology and biophysics from Vanderbilt University. Previously Entrepreneur-in-Residence at Third Rock Ventures, VP of Discovery Research & Innovation at TCR2 Therapeutics, and Director & Head of Investigational Biology at the Merck Exploratory Science Center.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.